Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

3. Sibutramine - Wikipedia

   en.wikipedia.org/wiki/Sibutramine

   Sibutramine is a serotonin–norepinephrine reuptake inhibitor (SNRI) that, in humans, reduces the reuptake of norepinephrine (by ~73%), serotonin (by ~54%), and dopamine (by ~16%), [ 22] thereby increasing the levels of these substances in synaptic clefts and helping enhance satiety; the serotonergic action, in particular, is thought to ...

4. Anti-obesity medication - Wikipedia

   en.wikipedia.org/wiki/Anti-obesity_medication

   e. Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat. These medications alter one of the fundamental processes of ...

5. Diet drugs Alli and Xenical may cause liver failure - AOL

   www.aol.com/2010/05/29/diet-drugs-alli-and...

   Users of Alli and Xenical, beware -- the diet drugs may cause liver failure, according to the U.S. Food and Drug Administration. In a statement released on May 26, the government agency said ...

6. AOL Mail

   mail.aol.com

   AOL Mail is free and helps keep you safe. From security to personalization, AOL Mail helps manage your digital life Start for free

7. Pfizer's twice-daily weight-loss pill discontinued due to ...

   www.aol.com/news/ozempic-without-injection...

   Pfizer announced on Dec. 1 that it was discontinuing phase 3 clinical trials of the twice-daily version due to high rates of adverse side effects. While these were mostly mild, a large percentage ...